UNISTRAIN® PRRS was presented at Edinburgh in 2013 within the framework of the ESPHM. The arrival of UNISTRAIN® PRRS provided an efficient alternative to European producers to better control PRRS with a live vaccine with potent immunogenic features and safety proved fulfilling all the EMA requirements.
In January 2014, UNISTRAIN® PRRS was launched in South Korea and it was received with great expectation. In South Korea, UNISTRAIN® PRRS demonstrated the capacity of the vaccine to proper control PRRSV2 and PRRSV1.
The first and unique combination of a PRRS live vaccine and a bivalent Erysipelas and porcine parvovirus vaccine was registered in Europe in 2014. This combination provides to the market a convenient and welfare-friendly vaccination to cover 3 of the most important reproductive diseases for the breeding herd.
PRRS is the trickiest disease with the highest economic impact in the swine industry. Prrscontrol.com was born to provide high quality and updated technical information to approach PRRS. Knowledge, video tutorials, experts answering questions and tools to control PRRS are the key contents you can find in.
With the official registration of the intradermal route for UNISTRAIN® PRRS, HIPRA presented the ID needle-free device for UNISTRAIN® PRRS: Hipradermic®. With this innovative device, HIPRA started the way of animal welfare, vaccination traceability, quality vaccination and better immunity that represents a step forward on PRRS control. Hipradermic® is an end to end project completely made by HIPRA.
In 2018, due to the growing demand for a deeper understanding of PRRSV epidemiology, HIPRA ceased outsourcing sequencing services and established an in-house, high-quality ORF5 sequencing service for our customers. This initiative entailed a significant investment in equipment, facilities, personnel and training.
The first and unique combination of two live vaccines, PRRS and Aujeszky vaccine, was registered. Moreover, this was the first combination that can be administered by both ID and IM route. This innovative combination provides to the market a convenient and welfare-friendly vaccination to cover two major swine diseases.
The complexity of the virus requires a better understanding of it. That’s why an upgrade to the sequencing services was introduced in 2021: partial sequencing from ORF2 to ORF7 allows our customers to gain a deeper understanding of the virus’s origin, evolution, and complexity.
At the beginning of 2023, HIPRA got the marketing authorization of UNISTRAIN® PRRS in Japan. This confirms UNISTRAIN® PRRS as a useful tool for controlling PRRS in Asia and demonstrates the cross-protection capacity of UNISTRAIN® PRRS against any type of PRRS viruses.
Download "THE BOOK FOR PRRS KNOWLEDGE":
The book is a compendium of answers to the main questions posed by professionals, students and researchers when they are face to face with PRRS on a daily basis. DOWNLOAD it now for FREE!
Informazioni di base sulla protezione dei dati personali:
Titolare del trattamento: LABORATORIOS HIPRA, S.A.
Finalità: Gestione del rapporto contrattuale e/o commerciale con HIPRA, incluso l’invio di notizie, promozioni e inviti a eventi sponsorizzati da HIPRA.
Base giuridica: Esecuzione del rapporto contrattuale e del legittimo interesse di HIPRA.
Destinatari: Terzi a cui HIPRA ha affidato servizi di cloud computing, sicurezza, auditing, mailing, supporto tecnico e informatico, nonché società del suo gruppo.
Diritti: Richiedere l'accesso e la rettifica o la cancellazione dei dati personali e altri diritti come spiegato nelle informazioni aggiuntive. Puoi vedere le informazioni aggiuntive dettagliate sulla protezione dei dati nella nostra Informativa sulla privacy.
Per ulteriori informazioni, puoi consultare le nostre informazioni dettagliate sulla Protezione dei dati.
基本個人資料保護資訊：
控制者: LABORATORIOS HIPRA, S.A.
目的: 管理與海博萊的合約和/或業務關係，包括發送新聞、宣傳和海博萊贊助的活動邀請。
法律依據: 合約關係的履行和海博萊的合法利益。
接收者: 海博萊委託提供雲端運算、安全、稽核、郵寄、技術和電腦支援服務的第三方以及其集團內的公司。
權利: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.
For further information, please check our detailed information on Data Protection.
Basic Personal Data Protection information:
Controller: LABORATORIOS HIPRA, S.A.
Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.
For further information, please check our detailed information on Data Protection.
Información básica sobre protección de datos:
Responsable del tratamiento: LABORATORIOS HIPRA, S.A.
Propósitos: Gestionar la relación contractual y comercial con HIPRA, incluido el envío de noticias, promociones e invitaciones a eventos patrocinados por HIPRA.
Fundamentos legales: Cumplimiento de la relación contractual e interés legítimo de HIPRA.
Destinatarios: Terceros a los que HIPRA ha encargado las tareas de computación en la nube, seguridad, auditoría, correo, servicios de soporte técnico e informático, así como empresas de su grupo.
Derechos: Solicitar el acceso y la rectificación o eliminación de los datos personales y otros derechos, tal como se explica en la información adicional. Puede ver la información adicional detallada sobre la protección de datos en nuestra Política de Privacidad.
Para obtener más información, consulte nuestra información detallada sobre Protección de datos.
